skip to content »

Dan L. Duncan Cancer Center

Houston, Texas

BCM has 25 departments and more than 90 research and patient-care centers.
Dan L. Duncan Cancer Center
not shown on screen

Funding Archive

Duncan Inter and Intra Programmatic Multi Investigator Pilot Projects

October 2010

The Dan L. Duncan Cancer Center will be coordinating a range of pilot projects open to all Cancer Center members funded through the Duncan Gift, NCI funds and other philanthropic sources. We are seeking multi-investigator proposals that cover the full range of cancer investigation along the translational continuum including basic, pre-clinical, clinical and population based or epidemiological research. Individual pilot programs may require more focus.

All proposals will require project descriptions, limited to 6 pages not including references, to be written in the standard NIH grant format. The applications should include specific aims, significance, innovation, approach, as well as a few references, a budget and budget justification, and biographical sketch(s). All proposals will be evaluated by peer review and scored in a manner that simulates the NIH peer review process. Cancer Center leadership may direct some awards in a way that assures balanced distribution of projects across programmatic and thematic spectrums or supports strategic aims.

Instructions for the Pilot Grant

Pilot Grant Proposal Submission Document

The Dan L. Duncan Cancer Center is seeking proposals that will increase interactions between multiple investigators within and between programs. Proposals will require at least two investigators – each from either a different focus group within one of the identified programs, or one investigator from an identified program and another investigator who may be aligned with a program, or an unaligned member. Consideration will be given to proposals that have a good potential to develop into externally funded multi investigator grants and budgets will be dependent on the number of investigators involved. This year there is a particular interest in funding projects in developing programs such as pancreatic and GI cancers as well as cancer prevention and population research.

Approximately four (4) one year grants of up to $120,000 (dependent on the number co-PI participants) will be awarded in this category. Proposals cannot exceed $120,000 in total costs. No indirect costs will be required. Funds awarded may be used as a direct match for CPRIT funding. Awards will be effective Jan. 1, 2011.

We encourage you to consult with your program leaders. For general questions, contact Shari Yepez, in the Dan L. Duncan Cancer Center Administrative Office at 713-798-2087.

Deadline for Submittal is Monday, Nov. 22, 2010.


Cancer Prevention Research Institute of Texas (CPRIT)

High-Impact/High-Risk Research Awards

Description: to seek to provide short-term funding to explore the feasibility of high-risk projects that, if successful, would contribute major new insights into the etiology, diagnosis, treatment, or prevention of cancer.

Amount: may request a total of $200,000 for a period of up to two (2) years, inclusive of both direct and indirect costs (indirect costs capped at 5 percent). Because of the nature of this funding mechanism, renewal applications will not be accepted.

Application: only ten applications allowed from BCM.

Deadlines:

Friday, March 9, 2012 – Pre-proposals, consistent with the RFA requirements, are due to the Dan L. Duncan Cancer Center no later than 5 p.m., March 9 to sharir@bcm.edu.

Pre-proposals must comprise an Abstract and Significance (5,000 characters including spaces), and an NIH Biosketch for the PI.

The abstract and significance sections are critical as CPRIT subsequently will use these to judge whether an application will be triaged or sent on for full review. Clearly explain the question or problem to be addressed and the approach to its answer or solution. The specific aims of the application must be obvious from the abstract, although they need not be restated verbatim. Clearly address how the proposed project, if successful, will have a major impact on the field of cancer research or on the care of patients with cancer. Summarize how the proposed research creates new paradigms or challenges existing ones. (see Section 10.4.3 of RFA)

Monday, March 19, 2012– Dan L. Duncan Cancer Center will announce the 10 applicants selected to move forward with full proposals.

Friday, May 25, 2012 – Final application due to Sponsored Programs, complete in the CPRIT online system and approved in BRAIN eSP2 on or before May 25th.

Individual Investigator Research Awards

Description: to support innovative research proposals addressing critically-important questions that will significantly advance knowledge of the causes, prevention, and/or treatment of cancer.

Amount: up to $500,000 in total costs per year for three years (indirects capped at 5 percent). Exceptions to the $500,000 per year limit may be requested if extremely well justified (see Section 10.3.9 of RFA for detailed instructions).

Application: a principal investigator may submit only one application as principal investigator; there is no limit on the number of applications allowed from BCM.

Deadlines:

Friday, May 25, 2012 – Final application due to the Office of Sponsored Programs, complete in the CPRIT online system and approved in BRAIN eSP2 on or before May 25th.

***For additional information, please visit the CPRIT web site, http://www.cprit.state.tx.us/funding-opportunities/. Please direct any questions to the Dan L. Duncan Cancer Center, 713-798-2087 or e-mail sharir@bcm.edu.

Shared Instrumentation Awards

Description: The Shared Instrumentation Award mechanism will support the acquisition of major research instrumentation that cannot be requested through other CPRIT programs and whose purchase can be justified on a shared-use basis to support the goals of scientifically meritorious cancer research projects.

Applications: Only one application allowed from BCM

A one page LOI of your proposal and one page budget can be submitted to Ted Yank (tyank@bcm.edu) by Wednesday, Sept. 7. Proposals will be reviewed by the Executive Committee of the Dan L. Duncan Cancer Center and the selected proposal P.I. will be notified by Sept. 13.

Thursday, Sept. 1: Dan L. Duncan Cancer Center will announce the selected application to move forward will a full proposal.

Tuesday, Nov. 22: Final application due to Sponsored Programs, complete in the CPRIT online system and approved in BRAIN eSP2.

More information can be found in the RFA. Contact Dean Edwards, Ph.D. (deane@bcm.edu) or C. Kent Osborne, M.D. (kosborne@bcm.edu) if you have questions about the RFA.


Cancer Prevention Research Institute of Texas (CPRIT)

Individual Investigator Research Awards

Description: to support innovative research proposals addressing critically-important questions that will significantly advance knowledge of the causes, prevention, and/or treatment of cancer.

Amount: up to $500,000 in total costs per year for three years (indirects capped at 5 percent). Exceptions to the $500,000 per year limit may be requested if extremely well justified (see Section 10.3.9 of RFA for detailed instructions).

Application: a principal investigator may submit only one application as principal investigator; there is no limit on the number of applications allowed from BCM.

Deadlines:

Monday, May 25, 2011 – Final application due to the Office of Sponsored Programs, complete in the CPRIT online system and approved in BRAIN eSP2

Shared Instrumentation Awards

Description: The Shared Instrumentation Award mechanism will support the acquisition of major research instrumentation that cannot be requested through other CPRIT programs and whose purchase can be justified on a shared-use basis to support the goals of scientifically meritorious cancer research projects.

Applications: Only one application allowed from BCM

A one page LOI of your proposal and one page budget can be submitted to Ted Yank (tyank@bcm.edu) by Wednesday, Sept. 7. Proposals will be reviewed by the Executive Committee of the Dan L. Duncan Cancer Center and the selected proposal P.I. will be notified by Sept. 13.

Thursday, Sept. 1: Dan L. Duncan Cancer Center will announce the selected application to move forward will a full proposal.

Tuesday, Nov. 22: Final application due to Sponsored Programs, complete in the CPRIT online system and approved in BRAIN eSP2.

More information can be found in the RFA. Contact Dean Edwards, Ph.D. (deane@bcm.edu) or C. Kent Osborne, M.D. (kosborne@bcm.edu) if you have questions about the RFA.

Early Translational Research Awards

Description: These awards support projects that "bridge the gap" between promising new discoveries achieved in the research laboratory and commercial development for a therapeutic, device, or diagnostic assay through activities up to and including preclinical proof-of-principle data that demonstrate applicability to the planned clinical scenario.

Amount: Awards of up to $1,000,000 in total costs will be made for a period ranging from one to three years.

Application: Only six applications allowed from BCM.

Deadlines:

Monday, Aug. 8, 2011

Pre-proposals, consistent with the RFA requirements, are due to the Dan L. Duncan Cancer Center no later than 5 p.m., Aug. 8, 2011 to Shari Yepez (sharir@bcm.edu).

Pre-proposals must comprise of an abstract and significance (5,000 characters including spaces) and an NIH Biosketch for the P.I.

The abstract and significance sections are critical as CPRIT subsequently will use these to judge whether an application will be triaged or sent on for full review. Clearly explain the question or problem to be addressed and the approach to its answer or solution. The specific aims of the application must be obvious from the abstract. Clearly address how the proposed project, if successful, will have a major impact on care of patients with cancer. Explain how this application provides a clear path for acquiring proof-of-principle data necessary for next-stage commercial development.

Monday, Aug. 29: Dan L. Duncan Cancer Center will announce the six (6) applications selected to move forward with full proposals.

Monday, Nov. 22: Final application submitted via the CPRIT Application Receipt System by 3 p.m., central time. Applications must be submitted in BRAIN eESP2 no less than five (5) working days prior to the sponsor's deadline.


Cancer Prevention and Research Institute of Texas (CPRIT)

The Cancer Prevention and Research Institute of Texas (CPRIT) has announced two new funding programs. Detailed information is on the CPRIT website. Below is a brief summary of each program, as well as the internal selection process for the High-Impact/High-Risk Research Award program:

High-Impact/High-Risk Research Awards

Description: to support relatively short-term projects that are innovative, developmental, or exploratory in nature and target new avenues of cancer research.

Amount: up to $200,000 total costs over two years (indirect costs capped at 5%)

Application: only eleven (11) applications allowed from BCM.

Deadlines:

Sept. 1, 2009 – Pre-proposals, consistent with the RFA requirements, are due to the Dan L. Duncan Cancer Center no later than 5pm Tuesday, Sept. 1, 2009.

Pre-proposals must comprise a 150-word abstract, a 150-word statement of significance, and an NIH Biosketch for the PI.
The abstract should clearly explain the question or problem to be addressed and the approach to its answer or solution. The statement of significance should address how the proposed project, if successful, will have a major impact on the field of cancer research or on the care of patients with cancer and summarize how the proposed research creates new paradigms or challenges existing ones. (N.B. The abstract and significance sections are critical as CPRIT subsequently will use these to judge whether an application will be triaged or sent on for full review.)

Sept. 8, 2009 – Dan L. Duncan Cancer Center will announce the 11 applicants selected to move forward with full proposals.

Oct. 1, 2009 – Final application due to Sponsored Programs, complete in the CPRIT online system and approved in BRAIN eSP2.

Individual Investigator Research Awards

Description: to support innovative research proposals addressing critically-important questions that will significantly advance knowledge of the causes, prevention, and/or treatment of cancer.

Amount: up to $1 million total costs annually for four years (indirects capped at 5%).

Application: a principal investigator may submit only one application as principal investigator; there is no limit on the number of applications allowed from BCM.

Deadlines:

Oct. 1, 2009 – Final application due to Sponsored Programs, complete in the CPRIT online system and approved in BRAIN eSP2

***For additional information, please visit the CPRIT website.


ACS-IRG Seed Funds for Cancer Research

The Dan L. Duncan Cancer Center is pleased to announce the availability of seed funds from the American Cancer Society Institutional Research Grant (IRG) #93-034-12. The funds support promising new cancer-related research projects by junior faculty. One-year grants in the amount of $30,000 will be awarded. Two projects will be open to any area of investigation with one reserved for special interest for population based or health disparities research.

Applicants must be full-time, tenure-track assistant professors, appointed during the past five years (on or after Jan. 1, 2002), who do not hold independent, nationally competitive research grants. Please submit your application electronically to cancercenter@bcm.edu by Monday, Dec. 1, 2008

ACS Summary Sheet, ACS Proposal Guidelines, ACS Allow Expenses Form


Dan L. Duncan Cancer Center Pilot Project Grant Announcement
July, 2008

The Dan L. Duncan Cancer Center is seeking proposals that cover the full range of cancer investigation including basic, translational, pre-clinical, clinical and population based or epidemiological research. This pilot project program is open to all Cancer Center Members.

While definitive direction from the new Cancer Prevention and Research Institute of Texas (CPRIT) has not yet been provided regarding funding priorities, preference will be given to projects which have a high potential of successfully competing for additional funding from the CPRIT. The general goal of the CPRIT is to create and expedite innovation in cancer research that enhances the potential for scientific and medical breakthroughs, and to attract, create or expand research capabilities which will create high quality new jobs for the State. Thus, projects should include inter and intra programmatic collaborations with an eye towards new and innovative concepts. Inter-institutional projects where there are matching funds from the partner institution are also encouraged.

All proposals will require a short (5-6 page) project description which should include specific aims, background & significance, preliminary studies and research design & methods as well as a few references. In addition, a budget, budget justification, and an NIH biographical sketch will be required. All proposals will be evaluated by peer review and scored in a manner that simulates the NIH peer review process. Cancer Center leadership may direct some awards in a way that assures balanced distribution of projects across programmatic and thematic spectrums or supports strategic aims.

Funds in these proposals can be used to support any expenses within BCM including staff salary support, supplies, but major equipment purchases or PI salary are not allowed.

Approximately 11 one year grants of $70,000 will be awarded in this category. Proposals cannot exceed $70,000 in total costs. No indirect costs will be required.

Deadline for Submittal is Sept. 8, 2008.

For general questions, please contact the Dan L. Duncan Cancer Center Administrative Office at 713.798.1354.


Helis Foundation Grants

The Cancer Center has established a relationship with the Helis Foundation. This past year 2 grants were funded for $100,000 each. Cancer Center Leadership expects three such grants to be available in this coming year. Helis Foundation review will be required for this grants, and a deadline for submittal has not yet been established.


Building Interdisciplinary Research Careers in Women's Health

http://grants.nih.gov/grants/guide/rfa-files/RFA-OD-05-002.html

RFA Number: RFA-OD-05-002
Release Date: Nov. 24, 2004
Letters of Intent Receipt Date(s): Jan. 22, 2005
Application Receipt Date(s): Feb. 23, 2005
Peer Review Date(s): June/July 2005
Council Review Date(s): Sept. 2005

Earliest Anticipated Start Date: Sept. 30, 2005

Executive Summary

The NIH Office of Research on Women's Health and its co-sponsors invite institutional career development award applications for Building Interdisciplinary Research Careers in Women's Health Career Development Programs, hereafter termed "Programs." Programs will support research career development of junior faculty members, known as Interdisciplinary Women's Health Research (IWHR) Scholars, who have recently completed clinical training or postdoctoral fellowships, and who are commencing basic, translational, behavioral, clinical and/or health services research relevant to women's health.

The goal of this initiative is to promote the performance of interdisciplinary research and transfer of findings that will benefit the health of women, including sex/gender similarities or differences in biology, health or disease. The programs will accomplish these goals by bridging advanced training with research independence, as well as bridging scientific disciplines or areas of interest. This will increase the number and skills of investigators at awardee institutions through a mentored research and career development experience leading to an independent interdisciplinary scientific career addressing women's health.

The NIH Institutes and Centers support biomedical and behavioral research and research training. The Agency for Healthcare Research and Quality (AHRQ) supports health services research and research training. The cosponsors are partnering with ORWH to support the career development of researchers in women's health within their respective missions.


Distinguished Achievement Award (Cancer)

NOTE: Faculty interested in applying for this award must have an acceptance letter from the Faculty Committee on Awards prior to submitting an application to the sponsor. For more information, please contact Michelle Almarez (713-798-6975) or Emily Hughes (713-798-6394) in the Office of Research.

The Faculty Committee on Awards requests nominations for the 2006 Freedom to Discover Award for Distinguished Achievement in Cancer Research sponsored by Bristol-Myers Squibb. This award is given to a scientist who has made an outstanding contribution to progress in cancer research in either laboratory or clinical studies. The award consists of $50,000 and a silver commemorative medallion.

Please distribute this award announcement to faculty in your department. If you wish to post or view a program flyer including detailed program information, please visit the following link: http://intranet.bcm.tmc.edu/index.cfm?tmp=research/oor/faaward/BMSCancer.pdf

To nominate someone, please send his or her curriculum vitae and a letter of nomination outlining the individual's relevant achievements to Rachel Cook at awards@bcm.edu by Sept. 15, 2005.

For further information on this or other funding opportunities, visit our website

If you know anyone who would like to join this research listserv, please ask them to send their request to subscribe to awards@bcm.edu

Ruth Anne Eatock, Ph.D.
Chair, Faculty Committee on Awards


Alliance for Cancer Gene Therapy Announces Request for Applications

Deadline: Feb. 23, 2005

The Alliance for Cancer Gene Therapy funds research aimed at furthering the development of gene therapy approaches to the treatment of cancer.

As part of this mission, AGCT invites applications for its 2005 ACGT Gene Therapy for Lymphoma & Leukemia Award pro- gram. The overall objectives of the program are to advance gene therapy into the causes, treatment, and prevention of lymphoma and leukemia by promoting basic, pre-clinical and clinical translational research approaches utilizing cells and genes as medicine. ACGT will direct the awards to gene therapy research that has demonstrated great promise, particularly those that are closer to clinical translation.

Candidates for the Gene Therapy for Lymphoma & Leukemia Award must hold an M.D., Ph.D., or equivalent degree and be a tenure-track or tenured faculty. The investigator must also be conducting original research as an independent faculty member. Although there are no citizenship restrictions, research supported by the award must be conducted at medical schools and research centers in the United States.

Grants of up to $1 million will be awarded over a period of three to five years (inclusive of a maximum of 10 percent indirect costs).

Visit the AGCT Web site to download the complete Request for Applications.

RFP Link: http://acgtfoundation.org/

For additional RFPs in Medical Research, visit: http://fdncenter.org/pnd/rfp/cat_medical_research.jhtml


Leukemia & Lymphoma Society Invites Applications for Translational Research Program

Deadline: March 1, 2005 (Preliminary application)

The Leukemia & Lymphoma Society ( http://www.lls.org/ ), a national health organization that sponsors research on leukemia, lymphoma, and myeloma, announces a call for preliminary applications for its Translational Research Program.

The program is designed to encourage and provide early- stage support for clinical research in leukemia, lymphoma, and myeloma that leads to the development of innovative approaches to treatment, diagnosis, and/or prevention. The program also fosters collaboration between basic and clinical scientists with the intent of enhancing the transfer of basic research findings to clinical usefulness. The program's purpose is to fund research that shows high promise for translating basic biomedical knowledge to prevention or new treatments and, ultimately, to prolong and enhance life.

Applications proposing novel approaches to the prevention, diagnosis, or treatment of leukemia, lymphoma, and myeloma are especially welcome. Proposals should be based on molecular, cellular, or integrated systems findings and be conceptually innovative.

The program is intended to provide support over an initial three-year period. In certain instances, funding for two additional years may be available.

Awards will be limited to a maximum of $200,000, which includes direct costs and a maximum overhead of $20,000, or 11.1 percent of direct costs, per year, for three years.

See the Leukemia & Lymphoma Society Web site for complete program information and application procedures.

RFP Link: http://fconline.fdncenter.org/pnd/527/lls

For additional RFPs in Medical Research, visit: http://fdncenter.org/pnd/rfp/cat_medical.jhtml


Fellowship Award - Damon Runyon Cancer Research Foundation

Deadline: March 3, 2005

This postdoctoral fellowship encourages all theoretical and experimental research relevant to the study of cancer and the search for cancer causes, mechanisms, therapies and prevention. For more information, visit the sponsor's website.


Association for International Cancer Research

Internet Address: http://www.aicr.org.uk/

Health Topic Areas: Cancer research

Eligible Applicants: The application must come from a suitably qualified researcher (minimum of PhD). PhD students are only funded from within a project grant.

Description: AICR's aim is to support fundamental research into the causes, mechanisms, diagnosis, treatment and prevention of cancer. The emphasis is on basic, as opposed to clinical research.

Application Deadline: April 29, 2005; Oct. 28, 2005

Contact Information:

AICR Grants Administration Office
Madras House
St Andrews, Fife, KY16 9EH

Tel: (01334) 477-910
Fax: (01334) 478-667
E-mail: alan.gilchrist@aicr.org.uk


Paul Marks Prize in Cancer Research

Deadline: April 29, 2005

The Memorial Sloan-Kettering Cancer Center is seeking nominations for the 2005 Paul Marks Prize in Cancer Research. The award recognizes investigators who have made significant contributions to understanding cancer or improving the treatment of cancer through basic or clinical research. The award consists of $150,000 and the deadline is April 29, 2005.

For more information, please visit the sponsor's website at: http://www.mskcc.org/mskcc/html/53983.cfm

This award does not require internal review, please apply directly to the sponsor. For a listing of other current funding opportunities, please visit our website.


Announcement of Grants for Cancer Center Pilot Projects

The BCM Cancer Center wishes to announce the availability of funding for Pilot Grants of $15,000 per year for 2 years. The funds are designated to support the early stage (or an expansion) of a collaborative project between two (or more) laboratories. The project should relate to cancer research, and preference will be given to applications with a strong potential for translational research. Project descriptions are limited to 5-6 pages not including references, but should be in a standard NIH grant format. The application should include specific aims, background & significance, preliminary studies, research design & methods, as well as a few references, in addition to a budget and budget justification, a biographical sketch and an other support page. Funds are not intended to provide PI salary support or to purchase equipment. Faculty at all levels are eligible to apply. Five copies of this application are due by 5:00 p.m. Monday, June 6, 2005. Applications should be delivered to Shari Stark, The Cancer Center, BCM Room 450A. Funding is available July 1, 2005.

For questions or additional information, please contact Ms. Stark at the Cancer Center, 713-798-2087.


ACS-IRG Seed Funds for Cancer Research

The Cancer Center is pleased to announce the availability of seed funds from the College's American Cancer Society Institutional Research Grant (IRG) #93-034-09. The funds support promising new cancer-related research projects by junior faculty. One-year grants in the amount of $20,000 will be awarded.

Applicants must be full-time, tenure-track assistant professors, appointed during the past five years (on or after Jan. 1, 2000), who do not hold independent, nationally competitive research grants. Previous recipients of the Biomedical Research Support Grant or other BCM faculty seed funding programs are not eligible for funding.

Applications guidelines and forms are available on the Cancer Center website at www.bcm.edu/cancercenter under Funding Opportunities. Please submit proposals (original and five copies) by Monday, June 6, 2005 to Shari Stark, The Cancer Center, BCM Suite 450A.

Questions should be directed to Ms. Stark at 713-798-2087 or sharir@bcm.edu

ACS Proposal Guidelines

ACS Summary Sheet


Medical Student Stipend

American Cancer Society Institutional Research Grant (IRG) #93-034-09

A $2,500 stipend from the College's American Cancer Society IRG is available to a medical student to spend time in a research laboratory while still employed in his or her degree program. The research must relate to cancer.

Please submit the following to The Cancer Center by Monday, June 6, 2005:

One-page application outlining the proposed research*
Letter of recommendation from the mentor supervising the research
Personal Statement (not to exceed one page)
Official Medical School Transcript

*Application form can be downloaded from the Cancer Center webpage (www.bcm.edu/cancercenter) under the Funding Opportunities Section.

2005 ACS Medical Student Stipend Application


Susan G. Komen Interdisciplinary Breast Fellowship Program

This award does not require internal review, if you would like to submit an application, please submit it directly to the sponsor.

The Susan G. Komen Breast Cancer Foundation is accepting applications for the Interdisciplinary Breast Fellowship Program. This award is intended to prepare highly motivated, talented and compassionate physicians for careers devoted to serving the multispecialty needs of the breast cancer patient. The program will find two consecutive one-year fellowships at $35,000 per year. The application deadline if Feb. 7, 2005.

For more information on this award, please visit the sponsor's website at:
http://www.komen.org/intradoc-cgi/idc_cgi_isapi.dll?IdcService=SS_GET_PAGE&nodeId=563

For other award opportunities, please visit the Intramural Funding & Awards website.


Cancer, Cardiovascular, Neuropsychiatry, Women in Medicine, Clinical, & Neuroscience Awards, Robert J. and Claire Pasarow Medical Prizes

Deadline: Jan. 17, 2005 - $35,000. These awards are intended for investigators who have made extraordinary accomplishments in cancer research, cardiovascular research, or neuropsychiatry research. For more information of this award, please visit the following link: http://intranet.bcm.tmc.edu/index.cfm?tmp=research/oor/faaward/Pasarow.pdf


****************************************************************** NOTE: Faculty interested in applying for this award must have an acceptance letter from the Faculty Committee on Awards prior to submitting an application to the sponsor. For more information, please contact Emily Hughes in the Office of Research (713-798-6394 or ehughes@bcm.edu) or Kelly Livesay (713-798-6978 or klivesay@bcm.edu). ******************************************************************

Damon Runyon Cancer Research Foundation
Damon Runyon Scholar Award

Nominations for the Damon Runyon Scholar Award sponsored by the Damon Runyon Cancer Research Foundation are being accepted. The award supports the development of outstanding scientists as independent investigators in the cancer field by helping foster their research productivity during the first few years of their faculty position. The award is $100,000 per year for three years.

The primary qualification for this award is that the applicant's scientific accomplishments show promise of future contributions that will lead to understanding the causes and mechanisms of cancer and to developing more effective cancer therapies and preventions. To be eligible a candidate must:

  • Be at the assistant professor or equivalent level
  • Be within the first three years of his or her initial faculty appointment
  • Not have another award expressly intended for career development running concurrently with the Damon Runyon Scholar Award. Non-U.S. citizens may apply only if they have a regular faculty appointment at a U.S. institution. Visiting appointments do not qualify.

An institution may nominate one physician-scientist (affiliated with a clinical department) and one basic scientist. If you would like to recommend someone for consideration by the Faculty Committee on Awards, please submit his or her curriculum vitae and a brief (not to exceed one page) summary of his or her research proposal via e-mail to awards@bcm.edu. A letter of nomination must also be submitted and may be sent via e-mail or interoffice mail to Emily Hughes, Office of Research, Room 600D. Nominations must be received by Friday, May 14, 2004.

For additional funding sources and award information, please see the Office of Research website (http://research.bcm.tmc.edu/Funding_Sources/funding_sources.html)


Bristol-Myers Squibb Award for Distinguished Achievement in Cancer Research

NOTE: Faculty interested in applying for this award must have an acceptance letter from the Faculty Committee on Awards prior to submitting an application. For more information, please contact Emily Hughes in the Office of Research at 713-798-6394 or ehughes@bcm.tmc.edu.

I am pleased to announce a request for nominations for the twenty-eighth annual Bristol-Myers Squibb Award for Distinguished Achievement in Cancer Research. The award recognizes a scientist who has made an outstanding contribution to progress in cancer research either in laboratory or clinical studies. Each recipient will receive a $50,000 prize and a silver commemorative medallion.

If you would like to recommend someone for consideration by the Faculty Committee on Awards, please send his or her curriculum vitae, a brief (not to exceed one page) summary of his or her applicable accomplishments, and a letter of nomination to Emily Hughes at awards@bcm.tmc.edu. Nominations must be received by Wednesday, Sept. 15, 2004.

Ruth Anne Eatock, Ph.D.
Chair, Faculty Committee on Awards

For additional funding sources and award information, please see the BCM Office of Research website (http://research.bcm.tmc.edu/Funding_Sources/funding_sources.html)


2005 Introduction to Cancer Research Careers (ICRC) Program

Please see this brochure for details

Call for Applications for Pilot/Feasibility Projects for Novel Approaches to Prostate Cancer Research and Therapy.

The NIH/NCI-funded Specialized Program of Research Excellence (SPORE) in prostate cancer (SPORE P50-CA58204) supports translational research in prostate cancer. The Baylor Prostate Cancer SPORE is in the process of evaluating novel ideas for translational research, especially in the areas of molecular genetic approaches for human prostate cancer tissue-based research, novel uses of steroids and steroid antagonists (e.g., antiandrogens) in prostate cancer therapy, and novel immunomodulatory approaches to gene therapy for prostate cancer. We are therefore requesting proposals for pilot/feasibility projects that are related to these specific areas of research. Although preference will be given to these specific areas, outstanding proposals for work in other areas will be considered. Applicants should hold full-time faculty position at the College. The applications should be up to six pages, including references, and should follow a basic NIH format that includes the four-page NIH Biosketch and Research Support information. The request should not exceed $25,000 annually for a one-year funding period. The deadline for the receipt of applications is Sept. 30, 2004.

Please send your applications to:

Kellie Poudrier,
Administrator for the Baylor SPORE in Prostate Cancer,
Scott Department of Urology, Baylor College of Medicine,
6560 Fannin, Suite 2100,
Houston, TX 77030
(telephone: 713-799-8718;
fax: 713-794-7983;
Email: poudrier@bcm.tmc.edu).


NCI Cancer Prevention Fellowship Program Available

The NCI is offering Cancer Prevention Fellowship Programs. Per Douglas Weed, Director of the Cancer Prevention Fellowship Program, writes that the program offers postdoctoral training in the field of cancer prevention and control, including molecular prevention, biomarkers and early detection, molecular epidemiology, clinical trials, behavioral and nutritional interventions, and ethics of prevention. Two specialty tracks are available:

  • Clinical Cancer Prevention Research
  • Ethics of Prevention and Public Health

Fellows have the opportunity to receive Master of Public Health (M.P.H.) training at accredited university programs in the first year, followed by independent research at the NCI. Other programs activities are NCI's Summer Curriculum in Cancer Prevention, grant writing and effective presentation workshops, weekly prevention and control lectures, and fellows' research meetings.

To review their catalog online, please access: http://cancer.gov/prevention/pob. The deadline for the receipt of applications is Sept. 1, 2004 for entrance into the program in the last week of June, 2005.

If you have any questions about the Program, please contact Dr. Weed or Mrs. Barbara Redding at (telephone) 301-496-8640, (fax) 301-402-4863 or (e-mail) br24v@nih.gov


Concert for the Cure, Inc. Breast Cancer Research Grant

****************************************************************** NOTE: Faculty interested in applying for this award must have an acceptance letter from the Faculty Committee on Awards prior to submitting an application to the sponsor. For more information, please contact Emily Hughes in the Office of Research at 713-798-6394 or ehughes@bcm.edu) or Kelly Livesay 713-798-6978 or klivesay@bcm.tmc.edu). ******************************************************************

Concert for the Cure, Inc.
Breast Cancer Research Grant

I am pleased to announce a request for nominations for the Breast Cancer Research Grant sponsored by Concert for the Cure, Inc. The grant provides up to $100,000 per year for up to three years to support an independent scientist involved in basic breast cancer research.

To be eligible, a candidate must plan to study the biology of cancer with the ultimate goal of clinical application of the discoveries. The candidate must be an independent laboratory investigator and must have independently assigned space. The duration of this independence must be less than three years as of January 2004.

If you would like to recommend someone for consideration by the Faculty Committee on Awards, please send a letter of nomination, his or her curriculum vitae, and a brief (not to exceed one page) summary of his or her proposed research project to Emily Hughes in the Office of Research (Room 600D). Nominations must be received by Wednesday, Feb. 18, 2004.

Ruth Anne Eatock, Ph.D.
Chair, Faculty Committee on Awards

E-mail this page to a friend